Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival

Author:

Cannioto Rikki A1ORCID,Hutson Alan2,Dighe Shruti1,McCann William1,McCann Susan E1ORCID,Zirpoli Gary R3,Barlow William4,Kelly Kara M5,DeNysschen Carol A16,Hershman Dawn L7ORCID,Unger Joseph M4ORCID,Moore Halle C F8ORCID,Stewart James A9,Isaacs Claudine10ORCID,Hobday Timothy J11,Salim Muhammad12,Hortobagyi Gabriel N13ORCID,Gralow Julie R14ORCID,Albain Kathy S15,Budd G Thomas8,Ambrosone Christine B1ORCID

Affiliation:

1. Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

2. Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

3. Slone Epidemiology Center, Boston University, Boston, MA, USA

4. SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

5. Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

6. Health, Nutrition, and Dietetics, State University of New York at Buffalo, Buffalo, NY, USA

7. Department of Medicine, Columbia University, New York, NY, USA

8. Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

9. Department of Hematology and Oncology, Baystate Medical Center, Springfield, MA, USA

10. Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, DC, USA

11. Department of Medical Oncology, Cancer Center, Mayo Clinic, Rochester, MN, USA

12. Medical Oncology, Allan Blair Cancer Centre, Regina, SK, Canada

13. Department of Breast Medical Oncology, Division of Cancer Medicine – Clinical, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

14. Breast Medical Oncology, Seattle Cancer Care Alliance, Seattle, WA, USA

15. Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA

Abstract

Abstract Background Although physical activity has been consistently associated with reduced breast cancer mortality, evidence is largely based on data collected at one occasion. We examined how pre- and postdiagnosis physical activity was associated with survival outcomes in high-risk breast cancer patients. Methods Included were 1340 patients enrolled in the Diet, Exercise, Lifestyle and Cancer Prognosis (DELCaP) Study, a prospective study of lifestyle and prognosis ancillary to a SWOG clinical trial (S0221). Activity before diagnosis, during treatment, and at 1- and 2-year intervals after enrollment was collected. Patients were categorized according to the Physical Activity Guidelines for Americans as meeting the minimum guidelines (yes/no) and incrementally as inactive, low active, moderately active (meeting the guidelines), or high active. Results In joint-exposure analyses, patients meeting the guidelines before and 1 year after diagnosis experienced statistically significant reductions in hazards of recurrence (hazard ratio [HR] = 0.59, 95% confidence interval [CI] = 0.42 to 0.82) and mortality (HR = 0.51, 95% CI = 0.34–0.77); associations were stronger at 2-year follow-up for recurrence (HR = 0.45, 95% CI = 0.31 to 0.65) and mortality (HR = 0.32, 95% CI = 0.19 to 0.52). In time-dependent analyses, factoring in activity from all time points, we observed striking associations with mortality for low- (HR = 0.41, 95% CI = 0.24 to 0.68), moderate- (HR = 0.42, 95% CI = 0.23 to 0.76), and high-active patients (HR = 0.31, 95% CI = 0.18 to 0.53). Conclusions Meeting the minimum guidelines for physical activity both before diagnosis and after treatment appears to be associated with statistically significantly reduced hazards of recurrence and mortality among breast cancer patients. When considering activity from all time points, including during treatment, lower volumes of regular activity were associated with similar overall survival advantages as meeting and exceeding the guidelines.

Funder

the Breast Cancer Research Foundation

Roswell Park Comprehensive Cancer Center and National Cancer Institute

National Cancer Institute, Division of Cancer Prevention SWOG NCORP Research Base

National Cancer Institute

National Clinical Trials Network

Amgen, Inc

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3